Global Antisense Oligonucleotide Drugs (ASO Drugs) Market Research Report 2022

Publisher Name :
Date: 02-Dec-2022
No. of pages: 88
Inquire Before Buying

A class of molecular drugs that inhibit gene expression and regulate at the gene level through sequence specific binding with target gene DNA or mRNA

Highlights

The global Antisense Oligonucleotide Drugs(ASO Drugs) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Antisense Oligonucleotide Drugs(ASO Drugs) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Antisense Oligonucleotide Drugs(ASO Drugs) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Antisense Oligonucleotide Drugs(ASO Drugs) include Lonis, Biogen, Sarepta, Novartis, Antisense Therapeutics, Akcea and WAVE, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Antisense Oligonucleotide Drugs(ASO Drugs) in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Hepatitis B, which accounted for % of the global market of Antisense Oligonucleotide Drugs(ASO Drugs) in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Drugs(ASO Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Drugs(ASO Drugs).

The Antisense Oligonucleotide Drugs(ASO Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antisense Oligonucleotide Drugs(ASO Drugs) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense Oligonucleotide Drugs(ASO Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Lonis

- Biogen

- Sarepta

- Novartis

- Antisense Therapeutics

- Akcea

- WAVE

Product Type Insights

Global markets are presented by Antisense Oligonucleotide Drugs(ASO Drugs) type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Antisense Oligonucleotide Drugs(ASO Drugs) are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Antisense Oligonucleotide Drugs(ASO Drugs) segment by Indication

- Hepatitis B

- Prostatitis

- Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Antisense Oligonucleotide Drugs(ASO Drugs) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antisense Oligonucleotide Drugs(ASO Drugs) market.

Antisense Oligonucleotide Drugs(ASO Drugs) segment by Application

- Hospital

- Clinic

- Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antisense Oligonucleotide Drugs(ASO Drugs) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antisense Oligonucleotide Drugs(ASO Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Antisense Oligonucleotide Drugs(ASO Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antisense Oligonucleotide Drugs(ASO Drugs) industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antisense Oligonucleotide Drugs(ASO Drugs).

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Antisense Oligonucleotide Drugs(ASO Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Antisense Oligonucleotide Drugs(ASO Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Analysis of sales channel, distributors and customers

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.

Chapter 11: The main points and conclusions of the report.

Global Antisense Oligonucleotide Drugs (ASO Drugs) Market Research Report 2022

Table of Contents
1 Antisense Oligonucleotide Drugs(ASO Drugs) Market Overview
1.1 Product Overview and Scope of Antisense Oligonucleotide Drugs(ASO Drugs)
1.2 Antisense Oligonucleotide Drugs(ASO Drugs) Segment by Indication
1.2.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Growth Rate Comparison by Indication (2022-2028)
1.2.2 Hepatitis B
1.2.3 Prostatitis
1.2.4 Other
1.3 Antisense Oligonucleotide Drugs(ASO Drugs) Segment by Application
1.3.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Size Estimates and Forecasts
1.4.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue 2017-2028
1.4.2 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales 2017-2028
1.4.3 Antisense Oligonucleotide Drugs(ASO Drugs) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antisense Oligonucleotide Drugs(ASO Drugs) Market Competition by Manufacturers
2.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antisense Oligonucleotide Drugs(ASO Drugs) Manufacturing Sites, Area Served, Product Type
2.5 Antisense Oligonucleotide Drugs(ASO Drugs) Market Competitive Situation and Trends
2.5.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antisense Oligonucleotide Drugs(ASO Drugs) Players Market Share by Revenue
2.5.3 Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antisense Oligonucleotide Drugs(ASO Drugs) Retrospective Market Scenario by Region
3.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antisense Oligonucleotide Drugs(ASO Drugs) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antisense Oligonucleotide Drugs(ASO Drugs) Market Facts & Figures by Country
3.3.1 North America Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country
3.3.2 North America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Market Facts & Figures by Country
3.4.1 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country
3.4.2 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Market Facts & Figures by Region
3.5.1 Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Region
3.5.2 Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Market Facts & Figures by Country
3.6.1 Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country
3.6.2 Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Market Facts & Figures by Country
3.7.1 Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country
3.7.2 Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antisense Oligonucleotide Drugs(ASO Drugs) Historic Market Analysis by Indication
4.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Indication (2017-2022)
4.2 Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Indication (2017-2022)
4.3 Global Antisense Oligonucleotide Drugs(ASO Drugs) Price by Indication (2017-2022)
5 Global Antisense Oligonucleotide Drugs(ASO Drugs) Historic Market Analysis by Application
5.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Application (2017-2022)
5.2 Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Application (2017-2022)
5.3 Global Antisense Oligonucleotide Drugs(ASO Drugs) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Lonis
6.1.1 Lonis Corporation Information
6.1.2 Lonis Description and Business Overview
6.1.3 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.1.5 Lonis Recent Developments/Updates
6.2 Biogen
6.2.1 Biogen Corporation Information
6.2.2 Biogen Description and Business Overview
6.2.3 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.2.5 Biogen Recent Developments/Updates
6.3 Sarepta
6.3.1 Sarepta Corporation Information
6.3.2 Sarepta Description and Business Overview
6.3.3 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.3.5 Sarepta Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Antisense Therapeutics
6.5.1 Antisense Therapeutics Corporation Information
6.5.2 Antisense Therapeutics Description and Business Overview
6.5.3 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.5.5 Antisense Therapeutics Recent Developments/Updates
6.6 Akcea
6.6.1 Akcea Corporation Information
6.6.2 Akcea Description and Business Overview
6.6.3 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.6.5 Akcea Recent Developments/Updates
6.7 WAVE
6.6.1 WAVE Corporation Information
6.6.2 WAVE Description and Business Overview
6.6.3 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product Portfolio
6.7.5 WAVE Recent Developments/Updates
7 Antisense Oligonucleotide Drugs(ASO Drugs) Manufacturing Cost Analysis
7.1 Antisense Oligonucleotide Drugs(ASO Drugs) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antisense Oligonucleotide Drugs(ASO Drugs)
7.4 Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antisense Oligonucleotide Drugs(ASO Drugs) Distributors List
8.3 Antisense Oligonucleotide Drugs(ASO Drugs) Customers
9 Antisense Oligonucleotide Drugs(ASO Drugs) Market Dynamics
9.1 Antisense Oligonucleotide Drugs(ASO Drugs) Industry Trends
9.2 Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
9.3 Antisense Oligonucleotide Drugs(ASO Drugs) Market Challenges
9.4 Antisense Oligonucleotide Drugs(ASO Drugs) Market Restraints
10 Global Market Forecast
10.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market Estimates and Projections by Indication
10.1.1 Global Forecasted Sales of Antisense Oligonucleotide Drugs(ASO Drugs) by Indication (2023-2028)
10.1.2 Global Forecasted Revenue of Antisense Oligonucleotide Drugs(ASO Drugs) by Indication (2023-2028)
10.2 Antisense Oligonucleotide Drugs(ASO Drugs) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antisense Oligonucleotide Drugs(ASO Drugs) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antisense Oligonucleotide Drugs(ASO Drugs) by Application (2023-2028)
10.3 Antisense Oligonucleotide Drugs(ASO Drugs) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antisense Oligonucleotide Drugs(ASO Drugs) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antisense Oligonucleotide Drugs(ASO Drugs) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Growth Rate Comparison by Indication (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antisense Oligonucleotide Drugs(ASO Drugs) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antisense Oligonucleotide Drugs(ASO Drugs) Manufacturing Sites and Area Served
Table 11. Manufacturers Antisense Oligonucleotide Drugs(ASO Drugs) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antisense Oligonucleotide Drugs(ASO Drugs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense Oligonucleotide Drugs(ASO Drugs) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Region (2017-2022) & (K Units)
Table 16. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Region (2017-2022)
Table 17. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Region (2017-2022)
Table 19. North America Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country (2017-2022) & (K Units)
Table 20. North America Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Country (2017-2022)
Table 21. North America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Country (2017-2022)
Table 23. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Country (2017-2022)
Table 25. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Country (2017-2022)
Table 33. Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Country (2017-2022)
Table 39. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales by Indication (2017-2022) & (K Units)
Table 40. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Indication (2017-2022)
Table 41. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Indication (2017-2022) & (US$ Million)
Table 42. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Share by Indication (2017-2022)
Table 43. Global Antisense Oligonucleotide Drugs(ASO Drugs) Price by Indication (2017-2022) & (US$/Unit)
Table 44. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units) by Application (2017-2022)
Table 45. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Application (2017-2022)
Table 46. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Share by Application (2017-2022)
Table 48. Global Antisense Oligonucleotide Drugs(ASO Drugs) Price by Application (2017-2022) & (US$/Unit)
Table 49. Lonis Corporation Information
Table 50. Lonis Description and Business Overview
Table 51. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 53. Lonis Recent Developments/Updates
Table 54. Biogen Corporation Information
Table 55. Biogen Description and Business Overview
Table 56. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 58. Biogen Recent Developments/Updates
Table 59. Sarepta Corporation Information
Table 60. Sarepta Description and Business Overview
Table 61. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 63. Sarepta Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 68. Novartis Recent Developments/Updates
Table 69. Antisense Therapeutics Corporation Information
Table 70. Antisense Therapeutics Description and Business Overview
Table 71. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 73. Antisense Therapeutics Recent Developments/Updates
Table 74. Akcea Corporation Information
Table 75. Akcea Description and Business Overview
Table 76. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 78. Akcea Recent Developments/Updates
Table 79. WAVE Corporation Information
Table 80. WAVE Description and Business Overview
Table 81. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product
Table 83. WAVE Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Antisense Oligonucleotide Drugs(ASO Drugs) Distributors List
Table 87. Antisense Oligonucleotide Drugs(ASO Drugs) Customers List
Table 88. Antisense Oligonucleotide Drugs(ASO Drugs) Market Trends
Table 89. Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
Table 90. Antisense Oligonucleotide Drugs(ASO Drugs) Market Challenges
Table 91. Antisense Oligonucleotide Drugs(ASO Drugs) Market Restraints
Table 92. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Forecast by Indication (2023-2028) & (K Units)
Table 93. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share Forecast by Indication (2023-2028)
Table 94. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Forecast by Indication (2023-2028) & (US$ Million)
Table 95. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share Forecast by Indication (2023-2028)
Table 96. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antisense Oligonucleotide Drugs(ASO Drugs)
Figure 2. Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Share by Indication in 2021 & 2028
Figure 3. Hepatitis B Product Picture
Figure 4. Prostatitis Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Antisense Oligonucleotide Drugs(ASO Drugs) Market Size (2017-2028) & (US$ Million)
Figure 12. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales (2017-2028) & (K Units)
Figure 13. Antisense Oligonucleotide Drugs(ASO Drugs) Sales Share by Manufacturers in 2021
Figure 14. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Antisense Oligonucleotide Drugs(ASO Drugs) Players: Market Share by Revenue in 2021
Figure 16. Antisense Oligonucleotide Drugs(ASO Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Region (2017-2022)
Figure 18. Global Antisense Oligonucleotide Drugs(ASO Drugs) Sales Market Share by Region in 2021
Figure 19. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Region (2017-2022)
Figure 20. Global Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Market Share by Region in 2021
Figure 21. United States Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Colombia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Antisense Oligonucleotide Drugs(ASO Drugs) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) by Indication (2017-2022)
Figure 45. Manufacturing Cost Structure of Antisense Oligonucleotide Drugs(ASO Drugs)
Figure 46. Manufacturing Process Analysis of Antisense Oligonucleotide Drugs(ASO Drugs)
Figure 47. Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs